Author: | Zelenetz, A. |
Article Title: | Proteasome inhibitors in non-Hodgkin's lymphoma |
Abstract: | Proteasome inhibition is emerging as a potential treatment strategy for a broadening variety of tumors, including NHL. This article gives background information as well as a review of recent study results. © Journal of the National Comprehensive Cancer Network. |
Keywords: | cancer chemotherapy; treatment response; clinical trial; conference paper; bortezomib; proteasome; proteasome inhibitor; mantle cell lymphoma; multiple myeloma; sensory neuropathy; boronic acids; protease inhibitors; pyrazines; thrombocytopenia; asthenia; lymphocytopenia; cancer inhibition; nonhodgkin lymphoma; non-hodgkin's lymphoma; lymphoma, non-hodgkin; follicular lymphoma; boronic acid derivative; proteinase inhibitor; pyrazine derivative; clinical trials; motor neuropathy; small vessel vasculitis; proteasome inhibitors; necrotizing arteritis |
Journal Title: | Journal of the National Comprehensive Cancer Network |
Volume: | 3 |
Issue: | Suppl. 1 |
ISSN: | 1540-1405 |
Publisher: | Harborside Press |
Date Published: | 2005-11-01 |
Start Page: | S34 |
End Page: | S36 |
Language: | English |
PUBMED: | 16280110 |
PROVIDER: | scopus |
DOI/URL: | |
Notes: | --- - "Export Date: 24 October 2012" - "Source: Scopus" |